Cargando…

Population Pharmacokinetics of Candesartan in Patients with Chronic Heart Failure

Heart failure (HF) causes pathological changes in multiple organs, thus affecting the pharmacokinetics (PK) of drugs. The aim of this study was to investigate the PK of candesartan in patients with HF while examining significant covariates and their related impact on estimated clearance using a popu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kassem, Imad, Sanche, Steven, Li, Jun, Bonnefois, Guillaume, Dubé, Marie‐Pierre, Rouleau, Jean‐Lucien, Tardif, Jean‐Claude, White, Michel, Turgeon, Jacques, Nekka, Fahima, de Denus, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877833/ https://www.ncbi.nlm.nih.gov/pubmed/32702160 http://dx.doi.org/10.1111/cts.12842

Ejemplares similares

Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model‐informed precision dosing trial simulations
por: Aljutayli, Abdullah, et al.
Publicado: (2022)

Pharmacogenomic study of heart failure and candesartan response from the CHARM programme
por: Dubé, Marie‐Pierre, et al.
Publicado: (2022)

Sex, drugs, and heart failure: a sex‐sensitive review of the evidence base behind current heart failure clinical guidelines
por: Levinsson, Anna, et al.
Publicado: (2018)

Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination
por: Fenneteau, Frédérique, et al.
Publicado: (2009)

Exploring an alternative explanation for the second phase of viral decay: Infection of short-lived cells in a drug-limited compartment during HAART
por: Sanche, Steven, et al.
Publicado: (2018)

Candesartan in heart failure
por: Ripley, Toni L, et al.
Publicado: (2006)

A genetic association study of heart failure: more evidence for the role of BAG3 in idiopathic dilated cardiomyopathy
por: de Denus, Simon, et al.
Publicado: (2020)

Candesartan cilexetil in the treatment of chronic heart failure
por: Baguet, Jean-Philippe, et al.
Publicado: (2009)

Understanding the Mechanisms and Treatment of Heart Failure: Quantitative Systems Pharmacology Models with a Focus on SGLT2 Inhibitors and Sex-Specific Differences
por: Ndiaye, Jean François, et al.
Publicado: (2023)

Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics
por: Bi, Goue Denis Gohore, et al.
Publicado: (2009)

Construction of a femininity score in the UK Biobank and its association with angina diagnosis prior to myocardial infarction
por: Levinsson, Anna, et al.
Publicado: (2022)

An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites
por: Pilon, Marc‐Olivier, et al.
Publicado: (2022)

A Mathematical Model to Predict HIV Virological Failure and Elucidate the Role of Lymph Node Drug Penetration
por: Sanche, S, et al.
Publicado: (2017)

Females present higher dose‐adjusted drug concentrations of metoprolol and allopurinol/oxypurinol than males
por: Hindi, Jessica, et al.
Publicado: (2023)

No pharmacokinetic interactions between candesartan and amlodipine following multiple oral administrations in healthy subjects
por: Kim, Jung-Ryul, et al.
Publicado: (2018)

Cost Effectiveness Analysis of Candesartan Therapy in Comparison to Candesartan-Amlodipine Therapy on Hypertensive Outpatients
por: Baroroh, Faridah, et al.
Publicado: (2019)

Trapezoid bioequivalence: A rational bioavailability evaluation approach on account of the pharmaceutical‐driven balance of population average and variability
por: Soufsaf, Sara, et al.
Publicado: (2022)

CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction
por: de Denus, Simon, et al.
Publicado: (2017)

Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation
por: Perreault, Sylvie, et al.
Publicado: (2022)

Changes in Cardiopulmonary Reserve and Peripheral Arterial Function Concomitantly with Subclinical Inflammation and Oxidative Stress in Patients with Heart Failure with Preserved Ejection Fraction
por: Vitiello, Damien, et al.
Publicado: (2014)

Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran
por: Ravangard, Ramin, et al.
Publicado: (2023)

Leveraging large observational studies to discover genetic determinants of drug concentrations: A proof‐of‐concept study
por: Meloche, Maxime, et al.
Publicado: (2022)

Candesartan—the next anti-amyloid drug?
por: Yasar, Sevil
Publicado: (2022)

Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice
por: Danigo, Aurore, et al.
Publicado: (2015)

Phasic Dopamine Changes and Hebbian Mechanisms during Probabilistic Reversal Learning in Striatal Circuits: A Computational Study
por: Schirru, Miriam, et al.
Publicado: (2022)

A mechanistic model of ADHD as resulting from dopamine phasic/tonic imbalance during reinforcement learning
por: Véronneau-Veilleux, Florence, et al.
Publicado: (2022)

Cardio classics revisited – focus on the role of candesartan
por: De Rosa, Maria Leonarda
Publicado: (2010)

Preparation of Candesartan and Atorvastatin Nanoparticles by Solvent Evaporation (†)
por: Vaculikova, Eliska, et al.
Publicado: (2012)

Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy
por: Colombo, Giorgio L, et al.
Publicado: (2008)

Design of the Prospective Comparison of Angiotensin Receptor-Neprilysin Inhibitor Versus Placebo in Patients With Congenital Systemic Right Ventricle Heart Failure (PARACYS-RV) Trial
por: Chaix, Marie-A., et al.
Publicado: (2023)

A Pharmacogenetic Investigation of Intravenous Furosemide in Decompensated Heart Failure: A Meta-Analysis of 3 Clinical Trials
por: de Denus, Simon, et al.
Publicado: (2016)

Simultaneous determination of pioglitazone and candesartan in human plasma by LC-MS/MS and its application to a human pharmacokinetic study
por: Kumari Karra, Vijaya, et al.
Publicado: (2012)

Modeling Testosterone Circadian Rhythm in Hypogonadal Males: Effect of Age and Circannual Variations
por: González-Sales, Mario, et al.
Publicado: (2015)

Synthesis of the Novel AT(1) Receptor Tracer [(18)F]Fluoropyridine–Candesartan via Click Chemistry
por: Abreu Diaz, Aida M., et al.
Publicado: (2020)

Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats
por: Murad, H.A., et al.
Publicado: (2017)

A genetic model of ivabradine recapitulates results from randomized clinical trials
por: Legault, Marc-André, et al.
Publicado: (2020)

Impact of amiodarone use on metoprolol concentrations, α‐OH‐metoprolol concentrations, metoprolol dosing and heart rate: A cross‐sectional study
por: Robert, Sabrina, et al.
Publicado: (2023)

Effects of adriamycin and candesartan on the collagen and elastin of the aorta in rats
por: Uhm, Jae-Sun, et al.
Publicado: (2014)

Candesartan could ameliorate the COVID-19 cytokine storm
por: Elkahloun, Abdel G., et al.
Publicado: (2020)

Candesartan cilexetil: COVID-19 pneumonia: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6irerrjqqsjv6clku5805h8a9o